ASIA

From natural health products to oil investment

BIOPROSPECT will become the latest in a string of biotech companies to diversify into oil and gas when it takes a 75% stake in unlisted explorer Frontier Gasfields.

Under a heads of agreement signed recently, biotechnology company BioProspect will subscribe for $1 million of new shares in Frontier for a 25% stake, with an option to acquire an extra 50% in two tranches...

Start a free trial to continue reading this article

Already have an account?

Subscribe now

A growing series of reports, each focused on a key discussion point for the energy sector, brought to you by the Energy News Bulletin Intelligence team.

A growing series of reports, each focused on a key discussion point for the energy sector, brought to you by the Energy News Bulletin Intelligence team.

editions

ENB CCS Report 2024

ENB’s CCS Report 2024 finds that CCS could be the much-needed magic bullet for Australia’s decarbonisation drive

editions

ENB Cost Report 2023

ENB’s latest Cost Report findings provide optimism as investments in oil and gas, as well as new energy rise.

editions

ENB Future of Energy Report 2023

ENB’s inaugural Future of Energy Report details the industry outlook on the medium-to-long-term future for the sector in the Asia Pacific region.

editions

ENB Cost Report 2021

This industry-wide report aims to understand current cost levels across the energy industry